Literature DB >> 6112274

Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.

J L Maddocks, D N Slater.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6112274      PMCID： PMC1437808          DOI： 10.1177/014107688007300811

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  3 in total

1.  Agranulocytosis and sepsis associated with prednisolone.

Authors:  R ROKSETH
Journal:  Lancet       Date:  1960-03-26       Impact factor: 79.321

2.  Toxic epidermal necrolysis: an eruption resembling scalding of the skin.

Authors:  A LYELL
Journal:  Br J Dermatol       Date:  1956-11       Impact factor: 9.302

3.  Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

Authors:  J R Collins
Journal:  South Med J       Date:  1968-04       Impact factor: 0.954
  3 in total
  6 in total

Review 1.  Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis.

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Atsushi Hashimoto; Shigeto Tohma
Journal:  J Hum Genet       Date:  2015-04-23       Impact factor: 3.172

2.  Bone marrow necrosis after treatment with sulphasalazine.

Authors:  J E Van de Pette; D T Cunnah; T M Shallcross
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

Review 3.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

4.  Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.

Authors:  H A Capell; T Pullar; J A Hunter
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067

6.  A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis.

Authors:  Mimari Kanazawa; Keiichi Tominaga; Akira Kanamori; Takanao Tanaka; Satoshi Masuyama; Shoko Watanabe; Keiichiro Abe; Akira Yamamiya; Kenichi Goda; Atsushi Irisawa
Journal:  Medicina (Kaunas)       Date:  2022-02-11       Impact factor: 2.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.